Bril V, Druzdz A, Grosskreutz J, Habib AA, et al. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Lancet Neurol 2023;22:383-394.
PMID: 37059507